Changing the culture of liver health, the conversation around liver disease, and the consideration paid to liver patients is a central pillar of the Global Liver Institute. Diverse depictions in...
This month we are fortunate to feature one of the world’s leading patient innovators, Robin Farmanfarmaian–this is no exaggeration, her book, The Patient as CEO, was a number one best...
Policy Perspective from GLI President & CEO: Introducing the inaugural issue of the Global Liver Institute (GLI) Health Policy Update. GLI is committed to providing the entire liver community...
By Donna Cryer I am honored today to be involved in two healthcare initiatives that are at the same time foundational and cutting edge. As a patient, particularly one active in the digital space,...
“What comes to mind when you hear the word liver? Onions? Or a miraculous and essential organ that performs more than 500 functions? If a celebrity like David Bowie is reported to die from liver...
As someone who has lived for more than thirty years with inflammatory bowel disease, twenty years post-liver transplant, and now exactly thirty days after bilateral knee replacements I feel I have...
From Donna Cryer, President and CEOGlobal Liver Institute On World Hepatitis Day we should be rejoicing that thanks to cutting edge research,breakthrough treatments are now available that can cure...
Mrs. Cryer to Represent Patient and Consumer Interests in the Development of a Nationwide Health Information Infrastructure Washington, DC (May 5, 2015) -- The Global Liver Institute is pleased to...
All People with Hepatitis C Deserve Lifesaving Treatment The undersigned organizations, medical providers, and community members are alarmed by the escalating crisis in access to new lifesaving...
A Letter to the Secretary of Health and Human Services September 10, 2014 The Honorable Sylvia Mathews BurwellSecretary of Health and Human ServicesDepartment of Health and Human Services200...
Recent News
Improvement within Clinical Trials Genentech/Roche is enhancing the accessibility of clinical trials by providing comprehensive patient support services. By tackling common barriers to participation – such as travel costs, distance, parking, childcare, conflicting...
Global Liver Institute Applauds U.S. Representative Nydia Velázquez’ Reintroduction of The Liver Illness, Visibility, Education and Research Act (LIVER Act)(Washington, D.C., May 31, 2024) – Global Liver Institute applauds U.S. Representative Nydia Velázquez...
Global Leaders Gather to Exchange Best Practices in Liver Health PolicyGlobal Liver Institute Convenes Fruitful Meeting on the Sidelines of WHA77(Geneva, Switzerland, May 29, 2024) – Global Liver Institute (GLI) convened esteemed global leaders for an event on the...
Exploring Viral Hepatitis: Types, Diagnosis, and TreatmentViral hepatitis, a group of infections affecting the liver, has long been a global health concern. As the seventh leading cause of death worldwide it stands out as the only communicable disease with rising...
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Join Global Liver Institute to Push Congress to Advance Priority Bills and Support Agency Efforts.In the post-election...
